Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Stage II Breast Cancer|Stage IIIA Breast Cancer|Triple-negative Breast Cancer
Interventions: DRUG: vorinostat|PROCEDURE: therapeutic conventional surgery|OTHER: laboratory biomarker analysis
Sponsor: University of Southern California
Collaborators: National Cancer Institute (NCI)